AKBA
Akebia Therapeutics, Inc. · Healthcare
Director Steven C Gilman sold $55K of Akebia Therapeutics, Inc.
Sold$55,169
$12.08Price
4,567Shares
−11%Stake
What AKBA did after the filing
Prices for AKBA after this filing aren't in yet.
Traded Mon, Jun 8. Filed Tue, Jun 9, 12:17 PM ET, during the session. Not investment advice.